Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AlgoRx Pharmaceuticals Inc.

Division of Anesiva Inc.
www.algorx.com

Latest From AlgoRx Pharmaceuticals Inc.

Where Are They Now?

In a new occasional series, START-UP will select companies it profiled in the past to find out what went according to plan, and what didn't. This month, we revisit four anti-infectives discovery companies first profiled in 2000 and draw out some lessons, both from their successes and from their failures, for those starting out today.
BioPharmaceutical

Early-Stage Funding: Fewer Start-Ups Raising Cash In '05

Fundraising among biotech firms classified as start-ups by Windhover's Strategic Intelligence Systems was way down in the first quarter of 2005 compared to the same quarter in 2004, perhaps reflecting the growing difficulties of early-stage fundraising as venture capitalists focus on companies with clinical-stage projects.
BioPharmaceutical Business Strategies

Biotech Financing Roundup: Where the Money's At

There's a perceived transatlantic divide when it comes to biotechnology financing. European firms, the conventional wisdom goes, lack VC the support of their North American counterparts and thus are at an inherent disadvantage. But an analysis of 2004's VC financing trends shows that on average, European biotechs have pulled in respectable Series A and Series B rounds--later stage financing is another story.
BioPharmaceutical Business Strategies

Start-Up Previews (7/04)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile groups: Pain Therapeutics, Cancer Diagnostics, and MRI Innovations. Plus these Start-Ups across Health Care: Cytovance Biologics Inc., Emergent Respiratory Products Inc., and Faust Pharmaceuticals.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Site Specific
      • Topical Delivery
      • Transdermal
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Anesiva Inc.
  • Senior Management
  • Gordon M Saul, CBO
    Richard B Carter, PhD, CSO
    Paul Hamelin, Pres. & COO
  • Contact Info
  • AlgoRx Pharmaceuticals Inc.
    Phone: (201) 325-6900
    500 Plaza Drive
    Secaucus, NJ 07094–3619
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register